Adalimumab effectively controls both anterior and posterior noninfectious uveitis associated with systemic inflammatory diseases: focus on Behçet’s syndrome-Reference-Cited by-同舟云学术

Adalimumab effectively controls both anterior and posterior noninfectious uveitis associated with systemic inflammatory diseases: focus on Behçet’s syndrome

Published:2020-03-10 Issue:3 Volume:28 Page:711-718
ISSN:0925-4692
Container-title:Inflammopharmacology
language:en
Short-container-title:Inflammopharmacol

Author:

Silvestri Elena,Bitossi Alice,Bettiol Alessandra,Emmi Giacomo,Urban Maria Letizia,Mattioli Irene,Di Scala Gerardo,Bacherini Daniela,Lopalco Giuseppe,Venerito Vincenzo,Iannone Florenzo,Vitale Antonio,Tosi Gian Marco,Rizzo Stanislao,Fabiani Claudia,Cantarini Luca,Virgili Gianni,Vannozzi Lorenzo,Prisco Domenico

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Pharmacology,Immunology

Link

http://link.springer.com/content/pdf/10.1007/s10787-020-00697-4.pdf

Reference26 articles.

1. Bitossi A, Bettiol A, Silvestri E et al (2019) Adalimumab accounts for long-term control of noninfectious uveitis also in the absence of concomitant DMARD treatment: a multicenter retrospective study. Mediators Inflamm 2019:1623847. https://doi.org/10.1155/2019/1623847

2. Braun J, Baraliakos X, Listing J, Sieper J (2005) Decreased incidence of anterior uveitis in patients with ankylosing spondylitis treated with the anti-tumor necrosis factor agents infliximab and etanercept. Arthritis Rheum 52:2447–2451. https://doi.org/10.1002/art.21197

3. Chen G, Goeddel DV (2002) TNF-R1 signaling: a beautiful pathway. Science 296:1634–1635. https://doi.org/10.1126/science.1071924

4. Cunningham ET, Stalder A, Sanna PP et al (1997) Localization of tumor necrosis factor receptor messenger RNA in normal and herpes simplex virus-infected mouse eyes. Invest Ophthalmol Vis Sci 38:9–15

5. Díaz-Llopis M, Salom D, Garcia-de-Vicuña C et al (2012) Treatment of refractory uveitis with adalimumab: a prospective multicenter study of 131 patients. Ophthalmology 119:1575–1581. https://doi.org/10.1016/j.ophtha.2012.02.018

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Efficacy of Adalimumab in Children with Chronic Non-infectious Posterior Uveitis and Panuveitis: A Retrospective Cohort Study;Ophthalmology and Therapy;2024-03-18

2. Behçet's syndrome;The Lancet;2024-03

3. Comparative Study of Adalimumab, Infliximab and Certolizumab Pegol in the Treatment of Cystoid Macular Edema Due to Behçet’S Desease;2024

4. Adalimumab rapidly controls both anterior and posterior inflammation in patients with ocular Behçet syndrome and non-infectious uveitis refractory to conventional therapy: a prospective, 6-month follow-up investigation;International Ophthalmology;2023-08-09

5. Behçet’s Disease Uveitis;Journal of Clinical Medicine;2023-05-24